Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Current Taxes (2023 - 2025)

Vivos Therapeutics' Current Taxes history spans 3 years, with the latest figure at $799000.0 for Q4 2025.

  • Quarterly results put Current Taxes at $799000.0 for Q4 2025, up 66.11% from a year ago — trailing twelve months through Dec 2025 was $799000.0 (up 66.11% YoY), and the annual figure for FY2025 was $799000.0, up 66.11%.
  • Current Taxes for Q4 2025 was $799000.0 at Vivos Therapeutics, up from $727000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $799000.0 in Q4 2025 to a low of $327000.0 in Q4 2023.
  • The 3-year median for Current Taxes is $582000.0 (2025), against an average of $583000.0.
  • The sharpest move saw Current Taxes skyrocketed 47.09% in 2024, then skyrocketed 66.11% in 2025.
  • Year by year, Current Taxes stood at $327000.0 in 2023, then skyrocketed by 47.09% to $481000.0 in 2024, then skyrocketed by 66.11% to $799000.0 in 2025.
  • According to Business Quant data, Current Taxes over the past three periods came in at $799000.0, $727000.0, and $631000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.